MAP1LC3A and cancer: We hypothesize that most cancer mutations located around cLIRs might exhibit weak influence, and we develop a model-based algorithm named pLAM to predict potential LAMs that significantly increase (Type I) or decrease (Type II) their binding potentials to LC3, using the Parzen window method (Eq. 13)18.